Yaqi Gan

508 total citations
10 papers, 360 citations indexed

About

Yaqi Gan is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Yaqi Gan has authored 10 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Cancer Research and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Yaqi Gan's work include Epigenetics and DNA Methylation (5 papers), Cancer-related gene regulation (5 papers) and RNA modifications and cancer (2 papers). Yaqi Gan is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Cancer-related gene regulation (5 papers) and RNA modifications and cancer (2 papers). Yaqi Gan collaborates with scholars based in China and United States. Yaqi Gan's co-authors include Gang Yin, Guang Shu, Yimin Li, Qing Xiao, Jiaxin Liu, Ruotong Tian, Tong Li, Zhengwei Zhou, Juanni Li and Yulong Peng and has published in prestigious journals such as PLoS ONE, Oncogene and Signal Transduction and Targeted Therapy.

In The Last Decade

Yaqi Gan

10 papers receiving 357 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yaqi Gan China	9	280	173	80	61	27	10	360
Shunsuke Misono Japan	11	271 1.0×	213 1.2×	68 0.8×	48 0.8×	17 0.6×	17	341
Weinan Xue China	12	208 0.7×	193 1.1×	81 1.0×	73 1.2×	23 0.9×	17	309
Saifei He China	10	205 0.7×	149 0.9×	55 0.7×	33 0.5×	20 0.7×	17	278
Zhengyan Chang China	13	312 1.1×	235 1.4×	47 0.6×	64 1.0×	24 0.9×	24	409
Zining Jin China	11	186 0.7×	136 0.8×	61 0.8×	74 1.2×	28 1.0×	28	309
Wenwen Du China	14	365 1.3×	240 1.4×	73 0.9×	94 1.5×	22 0.8×	22	476
Wolong Zhou China	12	304 1.1×	157 0.9×	79 1.0×	96 1.6×	38 1.4×	21	427
Yuanhui Lai China	10	274 1.0×	192 1.1×	60 0.8×	68 1.1×	29 1.1×	15	352
Hongbo Su China	11	201 0.7×	115 0.7×	40 0.5×	55 0.9×	22 0.8×	22	281
Sang Yean Kim South Korea	9	218 0.8×	134 0.8×	46 0.6×	34 0.6×	25 0.9×	12	297

Countries citing papers authored by Yaqi Gan

Since Specialization

Citations

This map shows the geographic impact of Yaqi Gan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yaqi Gan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yaqi Gan more than expected).

Fields of papers citing papers by Yaqi Gan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yaqi Gan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yaqi Gan. The network helps show where Yaqi Gan may publish in the future.

Co-authorship network of co-authors of Yaqi Gan

This figure shows the co-authorship network connecting the top 25 collaborators of Yaqi Gan. A scholar is included among the top collaborators of Yaqi Gan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yaqi Gan. Yaqi Gan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Shu, Guang, Jiaxin Liu, Shumin Deng, et al.. (2022). HDAC5, negatively regulated by miR‐148a‐3p, promotes colon cancer cell migration. Cancer Science. 113(8). 2560–2574. 8 indexed citations

2.

Liu, Jiaxin, Yimin Li, Qing Xiao, et al.. (2022). Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer. BMC Cancer. 22(1). 1038–1038. 9 indexed citations

3.

Li, Yimin, Yaqi Gan, Jiaxin Liu, et al.. (2022). Downregulation of MEIS1 mediated by ELFN1-AS1/EZH2/DNMT3a axis promotes tumorigenesis and oxaliplatin resistance in colorectal cancer. Signal Transduction and Targeted Therapy. 7(1). 87–87. 112 indexed citations

4.

Xiao, Qing, Yaqi Gan, Yimin Li, et al.. (2021). MEF2A transcriptionally upregulates the expression of ZEB2 and CTNNB1 in colorectal cancer to promote tumor progression. Oncogene. 40(19). 3364–3377. 39 indexed citations

5.

Liu, Jiaxin, Yimin Li, Yaqi Gan, et al.. (2021). Identification of ZNF26 as a Prognostic Biomarker in Colorectal Cancer by an Integrated Bioinformatic Analysis. Frontiers in Cell and Developmental Biology. 9. 671211–671211. 5 indexed citations

6.

Li, Juanni, Ayesha B. Alvero, Sudhakar V. Nuti, et al.. (2020). CBX7 binds the E-box to inhibit TWIST-1 function and inhibit tumorigenicity and metastatic potential. Oncogene. 39(20). 3965–3979. 28 indexed citations

7.

Li, Yimin, Jiaxin Liu, Qing Xiao, et al.. (2020). EN2 as an oncogene promotes tumor progression via regulating CCL20 in colorectal cancer. Cell Death and Disease. 11(7). 604–604. 27 indexed citations

8.

Li, Tong, Wenjuan Zhou, Yimin Li, et al.. (2019). MiR-4524b-5p/WTX/β-catenin axis functions as a regulator of metastasis in cervical cancer. PLoS ONE. 14(4). e0214822–e0214822. 16 indexed citations

9.

Li, Tong, Yimin Li, Yaqi Gan, et al.. (2019). Methylation-mediated repression of MiR-424/503 cluster promotes proliferation and migration of ovarian cancer cells through targeting the hub gene KIF23. Cell Cycle. 18(14). 1601–1618. 38 indexed citations

10.

Gan, Yaqi, Yimin Li, Tong Li, Guang Shu, & Gang Yin. (2018). CCNA2 acts as a novel biomarker in regulating the growth and apoptosis of colorectal cancer. Cancer Management and Research. Volume 10. 5113–5124. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact